BLFS Relative Valuation
BLFS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BLFS is overvalued; if below, it's undervalued.
Historical Valuation
BioLife Solutions Inc (BLFS) is now in the Fair zone, suggesting that its current forward PS ratio of 9.91 is considered Fairly compared with the five-year average of -1562.16. The fair price of BioLife Solutions Inc (BLFS) is between 13.14 to 28.94 according to relative valuation methord.
Relative Value
Fair Zone
13.14-28.94
Current Price：25.68
Fair
-3208.00
PE
1Y
3Y
5Y
Trailing
Forward
37.03
EV/EBITDA
BioLife Solutions Inc. (BLFS) has a current EV/EBITDA of 37.03. The 5-year average EV/EBITDA is 91.85. The thresholds are as follows: Strongly Undervalued below -132.64, Undervalued between -132.64 and -20.40, Fairly Valued between 204.09 and -20.40, Overvalued between 204.09 and 316.34, and Strongly Overvalued above 316.34. The current Forward EV/EBITDA of 37.03 falls within the Historic Trend Line -Fairly Valued range.
-411.55
EV/EBIT
BioLife Solutions Inc. (BLFS) has a current EV/EBIT of -411.55. The 5-year average EV/EBIT is -119.38. The thresholds are as follows: Strongly Undervalued below -1132.90, Undervalued between -1132.90 and -626.14, Fairly Valued between 387.39 and -626.14, Overvalued between 387.39 and 894.15, and Strongly Overvalued above 894.15. The current Forward EV/EBIT of -411.55 falls within the Historic Trend Line -Fairly Valued range.
9.91
PS
BioLife Solutions Inc. (BLFS) has a current PS of 9.91. The 5-year average PS is 8.87. The thresholds are as follows: Strongly Undervalued below 1.25, Undervalued between 1.25 and 5.06, Fairly Valued between 12.68 and 5.06, Overvalued between 12.68 and 16.49, and Strongly Overvalued above 16.49. The current Forward PS of 9.91 falls within the Historic Trend Line -Fairly Valued range.
40.06
P/OCF
BioLife Solutions Inc. (BLFS) has a current P/OCF of 40.06. The 5-year average P/OCF is 57.81. The thresholds are as follows: Strongly Undervalued below -161.68, Undervalued between -161.68 and -51.93, Fairly Valued between 167.55 and -51.93, Overvalued between 167.55 and 277.29, and Strongly Overvalued above 277.29. The current Forward P/OCF of 40.06 falls within the Historic Trend Line -Fairly Valued range.
442.64
P/FCF
BioLife Solutions Inc. (BLFS) has a current P/FCF of 442.64. The 5-year average P/FCF is 4.38. The thresholds are as follows: Strongly Undervalued below -984.49, Undervalued between -984.49 and -490.06, Fairly Valued between 498.81 and -490.06, Overvalued between 498.81 and 993.24, and Strongly Overvalued above 993.24. The current Forward P/FCF of 442.64 falls within the Historic Trend Line -Fairly Valued range.
BioLife Solutions Inc (BLFS) has a current Price-to-Book (P/B) ratio of 3.32. Compared to its 3-year average P/B ratio of 2.69 , the current P/B ratio is approximately 23.36% higher. Relative to its 5-year average P/B ratio of 3.28, the current P/B ratio is about 0.97% higher. BioLife Solutions Inc (BLFS) has a Forward Free Cash Flow (FCF) yield of approximately 1.01%. Compared to its 3-year average FCF yield of -1.74%, the current FCF yield is approximately -158.14% lower. Relative to its 5-year average FCF yield of -1.56% , the current FCF yield is about -164.97% lower.
3.32
P/B
Median3y
2.69
Median5y
3.28
1.01
FCF Yield
Median3y
-1.74
Median5y
-1.56
Competitors Valuation Multiple
The average P/S ratio for BLFS's competitors is 4.44, providing a benchmark for relative valuation. BioLife Solutions Inc Corp (BLFS) exhibits a P/S ratio of 9.91, which is 123.25% above the industry average. Given its robust revenue growth of 28.94%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BLFS decreased by 0.77% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -28.20 to -62.30.
The secondary factor is the Revenue Growth, contributed 28.94%to the performance.
Overall, the performance of BLFS in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is BioLife Solutions Inc (BLFS) currently overvalued or undervalued?
What is BioLife Solutions Inc (BLFS) fair value?
How does BLFS's valuation metrics compare to the industry average?
What is the current P/B ratio for BioLife Solutions Inc (BLFS) as of Aug 14 2025?
What is the current FCF Yield for BioLife Solutions Inc (BLFS) as of Aug 14 2025?
What is the current Forward P/E ratio for BioLife Solutions Inc (BLFS) as of Aug 14 2025?